AGT and osteoporosis: Additionally, RAS modulation with AngII, ACEI, and ARBs (type 1 and type 2 receptors) assessed in experimental disease models of osteoporosis, spontaneous and induced hypertension, diabetes, and knockout models [8,10,17,18,19] showed both positive results [20,21] or no effect [22,23].